The EPO published patent application EP3873443A1 for solid dispersions and pharmaceutical compositions containing substituted indane compounds, filed by Peloton Therapeutics, Inc. The invention relates to methods for preparing and using these compositions, classified under IPC codes covering pharmaceutical formulations (A61K 9/14, A61K 9/20), active compounds (A61K 31/275, A61K 31/277), and therapeutic applications (A61P 9/12).

This is a patent publication rather than a regulatory action—it does not impose compliance obligations, reporting requirements, or deadlines on pharmaceutical companies. Companies engaged in formulation development should review the patent claims to assess potential freedom-to-operate implications for products using similar solid dispersion technologies.